Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy

被引：0
作者：
Michael Dieckmeyer
Stefan Ruschke
Alexander Rohrmeier
Jan Syväri
Ingo Einspieler
Vanadin Seifert-Klauss
Monika Schmidmayr
Stephan Metz
Jan S. Kirschke
Ernst J. Rummeny
Claus Zimmer
Dimitrios C. Karampinos
Thomas Baum
机构：
[1] Technische Universität München,Department of Diagnostic and Interventional Neuroadiology, Klinikum rechts der Isar
[2] Technische Universität München,Department of Radiology, Klinikum rechts der Isar
[3] University Medical Center Regensburg,Department of Radiology
[4] Technische Universität München,Department of Gynecology and Obstetrics, Klinikum rechts der Isar
来源：
BMC Musculoskeletal Disorders | / 20卷
关键词：
Osteoporosis; Bisphosphonates; Aromatase inhibitor; Vertebral bone marrow; Proton density fat fraction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[31]   Effects of zoledronic acid on bone mineral density during aromatase inhibitor treatment of Korean postmenopausal breast cancer patients [J].
Lee, Seung Ah ;
Hwang, Seung Hyun ;
Ahn, Sung Gwe ;
Lee, Hak Min ;
Jeong, Joon ;
Lee, Hy-De .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (03) :863-870
[32]   The influence of bone mineral density and bisphosphonate therapy on the determinants of oral health and changes on dental panoramic radiographs in postmenopausal women [J].
Grgic, Olja ;
Kovacev-Zavisic, Branka ;
Veljovic, Tanja ;
Novakovic-Paro, Jovanka ;
Maravic, Tatjana ;
Bajkin, Branislav .
CLINICAL ORAL INVESTIGATIONS, 2017, 21 (01) :151-157
[33]   The influence of bone mineral density and bisphosphonate therapy on the determinants of oral health and changes on dental panoramic radiographs in postmenopausal women [J].
Olja Grgić ;
Branka Kovačev-Zavišić ;
Tanja Veljović ;
Jovanka Novaković-Paro ;
Tatjana Maravić ;
Branislav Bajkin .
Clinical Oral Investigations, 2017, 21 :151-157
[34]   Aromatase Inhibitor Adjuvant Chemotherapy of Breast Cancer Results in Cancer Therapy Induced Bone Loss [J].
Renee Z. Rinaldi .
Current Osteoporosis Reports, 2013, 11 :61-64
[35]   Changes in serum estradiol levels with Estring in postmenopausal women with breast cancer treated with aromatase inhibitors [J].
Streff, Alyssa ;
Chu-Pilli, Michele ;
Stopeck, Alison ;
Chalasani, Pavani .
SUPPORTIVE CARE IN CANCER, 2021, 29 (01) :187-191
[36]   Changes in serum estradiol levels with Estring in postmenopausal women with breast cancer treated with aromatase inhibitors [J].
Alyssa Streff ;
Michele Chu-Pilli ;
Alison Stopeck ;
Pavani Chalasani .
Supportive Care in Cancer, 2021, 29 :187-191
[37]   Aromatase Inhibitor Adjuvant Chemotherapy of Breast Cancer Results in Cancer Therapy Induced Bone Loss [J].
Rinaldi, Renee Z. .
CURRENT OSTEOPOROSIS REPORTS, 2013, 11 (01) :61-64
[38]   Associations of gestational diabetes and proton density fat fraction of vertebral bone marrow and paraspinal musculature in premenopausal women [J].
Harada, Saori ;
Gersing, Alexandra S. ;
Stohldreier, Yannick ;
Dietrich, Olaf ;
Lechner, Andreas ;
Seissler, Jochen ;
Ferrari, Uta ;
Pappa, Eleni ;
Hesse, Nina .
FRONTIERS IN ENDOCRINOLOGY, 2024, 14
[39]   Managing bone loss in women with early-stage breast cancer receiving aromatase inhibitors [J].
Brufsky, Adam M. .
CLINICAL BREAST CANCER, 2007, 8 :S22-S34
[40]   Efficacy of a combined alendronate and calcitriol agent (Maxmarvil®) in Korean postmenopausal women with early breast cancer receiving aromatase inhibitor: a double-blind, randomized, placebo-controlled study [J].
Rhee, Yumie ;
Song, Kijun ;
Park, Seho ;
Park, Hyung Seok ;
Lim, Sung-Kil ;
Park, Byeong Woo .
ENDOCRINE JOURNAL, 2013, 60 (02) :167-172
12345